Immunotherapy for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsPancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
/in Dendritic Cells, International Publications, Pancreatic CancerA pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
/in Dendritic Cells, International Publications, Pancreatic CancerElectro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis
/in Glioblastoma, Hyperthermia, International PublicationsIrradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
/in Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenA prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
/in Dendritic Cells, Exosome, International PublicationsHyperthermia induces apoptosis by targeting Survivin in esophageal cancer
/in Esophageal Carcinoma, Hyperthermia, International PublicationsImmunotherapy of Brain Tumors
/in Brain Tumors in Children, Dendritic Cells, International PublicationsFueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
/in Checkpoint-Inhibitors, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer